openPR Logo
Press release

Cell Therapy Market Estimated Share Reaches at 31.2 Billion USD, exhibiting a CAGR of 8.58% During 2025 to 2032

02-17-2025 09:28 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Cell Therapy Market Overview 2025

Cell Therapy Market Overview 2025

Cell Therapy Market Growth Information By Cell Type (Stem Cell and Non-Stem Cell), By Therapy Type (Autologous and Allogeneic), By Therapeutic Area (Malignancies, Musculoskeletal Disorders, Autoimmune Disorders, Dermatology, and Others), By End User (Hospitals & Clinics and Academic & Research Institutes), and By Region (North America, Europe, Asia-Pacific, and Rest Of The World) - Industry Forecast Till 2032
The cell therapy market growth [https://www.marketresearchfuture.com/reports/cell-therapy-market-5066] is experiencing rapid expansion, driven by significant advancements in gene and immune therapies, alongside a growing demand for personalized treatment options. Innovations in regenerative medicine, including stem cell and CAR-T therapies, are propelling this growth. Technological progress in cell manufacturing and increased investment in clinical trials further bolster the market's expansion. Therapies targeting conditions such as cancer, autoimmune disorders, and musculoskeletal diseases are expected to continue evolving, contributing to substantial market growth.

Market Dynamics

The cell therapy market is projected to grow from USD 16.14 billion in 2024 to USD 31.2 billion by 2032, driven by increased funding in clinical research, practical manufacturing methods, and successful product innovations. Key trends include advancements in automated cell production devices, such as the Cell Factory Box, and new treatments like CAR-T cell therapy for cancer. The market is also benefiting from increasing adoption of advanced therapies for various conditions, including malignancies, autoimmune disorders, and musculoskeletal diseases.

Sample Copy of the Report @ https://www.marketresearchfuture.com/sample_request/5066

Recent Developments

Regulatory Approvals: In November 2024, the U.S. Food and Drug Administration (FDA) approved CARVYKTI (ciltacabtagene autoleucel), a CAR T-cell therapy for the treatment of relapsed or refractory multiple myeloma. This approval marks a significant advancement in cell therapy for hematological malignancies.

Strategic Acquisitions: In September 2024, AstraZeneca acquired Gracell Biotechnologies for up to $1.2 billion, aiming to enhance its cell therapy pipeline, particularly in CAR-T cell therapies for various cancers. This acquisition underscores the growing interest in cell therapy technologies.

Manufacturing Innovations: Companies like Cellares are developing automated manufacturing platforms, such as the Cell Shuttle, to streamline the production of cell therapies, potentially reducing costs and increasing accessibility.

Market Segmentation

By Therapy Type:

Autologous Therapies: Utilize a patient's own cells, reducing the risk of immune rejection.

Allogeneic Therapies: Use donor cells, offering the potential for off-the-shelf treatments.

By Therapeutic Area:

Oncology: Cell therapies targeting various cancers, including hematological and solid tumors.

Autoimmune Disorders: Treatments aimed at modulating the immune system to address autoimmune conditions.

Musculoskeletal Diseases: Therapies focused on repairing or replacing damaged tissues in bones, muscles, and joints.

By Region:

North America: Dominates the market due to advanced healthcare infrastructure and significant research investments.

Europe: Experiences steady growth, supported by supportive regulatory frameworks and increasing clinical trials.

Asia-Pacific: Emerging as a key market with rising healthcare investments and a large patient population.

Key Players

Prominent companies in the cell therapy market include:

Novartis AG: Known for Kymriah, a CAR T-cell therapy for certain types of leukemia and lymphoma.

Gilead Sciences, Inc.: Developed Yescarta, a CAR T-cell therapy for large B-cell lymphoma.

Bristol-Myers Squibb Company: Offers Breyanzi, a CAR T-cell therapy for relapsed or refractory large B-cell lymphoma.

Johnson & Johnson Services, Inc.: Involved in developing various cell therapy treatments.

JCR Pharmaceuticals Co., Ltd.: Specializes in cell-based therapies for rare diseases.

JW Therapeutics: Focuses on developing cell therapies for cancer treatment.

Atara Biotherapeutics: Engaged in developing T-cell immunotherapies for cancer and autoimmune diseases.

Anterogen Co., Ltd.: Develops stem cell-based therapies for musculoskeletal diseases.

MEDIPOST: Specializes in stem cell therapies for orthopedic and neurological conditions.

S. BIOMEDICS: Focuses on developing cell therapies for various medical conditions.

You Can Purchase Complete Report @ https://www.marketresearchfuture.com/checkout?currency=one_user-USD&report_id=5066

Challenges and Opportunities

While the cell therapy market presents significant growth opportunities, it also faces challenges such as high treatment costs, complex manufacturing processes, and regulatory hurdles. Addressing these challenges through technological innovations, strategic collaborations, and supportive policies can enhance the accessibility and affordability of cell therapies, thereby expanding their application across various medical fields.

Media Contact
Company Name: Market Research Future
Contact Person: Media Relations
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=cell-therapy-market-estimated-share-reaches-at-312-billion-usd-exhibiting-a-cagr-of-858-during-2025-to-2032]
Country: United States
Website: https://www.marketresearchfuture.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Cell Therapy Market Estimated Share Reaches at 31.2 Billion USD, exhibiting a CAGR of 8.58% During 2025 to 2032 here

News-ID: 3872443 • Views:

More Releases from ABNewswire

Dumbwood Announces Retail Launch on July 26, Ready to Turn Summer Break into a Game Night Adventure with AI-Powered TV Games
Dumbwood Announces Retail Launch on July 26, Ready to Turn Summer Break into a G …
From free-to-play charades to customizable trivia, Dumbwood's kid-friendly game platform makes screen time social, creative, and unforgettable. Image: https://www.abnewswire.com/upload/2025/07/4914fbed0c2a65a3060a6793b4250919.jpg Dumbwood [http://dumbwood.com/], the AI-assisted retro-style group gaming platform, has officially announced its retail launch date: July 26, 2024. Designed specifically for kids ages 13-15, Dumbwood offers a one-of-a-kind experience where users can create and play TV-based group games with the help of generative AI, just in time for summer break. Available on Fire TV
Montgomery Roofing - Lorena Roofers Offers Financing Plans to Make Roof Replacements More Affordable
Montgomery Roofing - Lorena Roofers Offers Financing Plans to Make Roof Replacem …
A damaged roof compromises a home's safety and energy efficiency. Rather than risking DIY fixes, homeowners should rely on a trusted roof replacement service like Montgomery Roofing. Their experienced team uses high-quality materials and follows industry best practices, ensuring long-lasting results. Whether searching for "roof replacement near me" or scheduling an inspection, customers can expect prompt, professional service tailored to their needs. When a storm damages your roof, waiting too long
Leading Provider of Accounting Services in Chicago, IL Sees Surge in Demand as New Entrepreneurs Seek Professional Financial Guidance
Leading Provider of Accounting Services in Chicago, IL Sees Surge in Demand as N …
Chicago, IL - As entrepreneurship continues to flourish across the United States, Jeff Badu, a licensed Certified Public Accountant and wealth multiplier, reports a significant increase in demand from new business owners seeking expert financial guidance. The surge reflects a growing recognition among entrepreneurs that professional financial management is crucial for long-term business success and growth. When establishing a new business, one of the most critical decisions entrepreneurs make is selecting
Top Real Estate Listing Agent in Pleasant View, UT, Expands Services to Help Homeowners Navigate Changing Market Conditions
Top Real Estate Listing Agent in Pleasant View, UT, Expands Services to Help Hom …
PLEASANT VIEW, UT - Responding to evolving real estate trends, Richard Curtis announces expanded services designed to help homeowners successfully navigate today's dynamic housing market. With innovative solutions tailored to current conditions, Curtis continues the client-centered approach that has defined his practice since 2002. Curtis, recognized by many as one of the top Realtors in Pleasant View, UT [https://www.abnewswire.com/pressreleases/top-real-estate-agent-in-pleasant-view-ut-celebrates-over-two-decades-of-clientfocused-excellence_744146.html], brings more than two decades of experience to clients facing today's unique

All 5 Releases


More Releases for Cell

Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Banking Outsourcing Market Report 2018: Segmentation by Type of Bank (Maste …
Global Cell Banking Outsourcing market research report provides company profile for Charles River Laboratories, Cryo-Cell International Inc., BioOutsource (Part of Sartorious Stedim Biotech Group)Ltd., BioReliance Corporation, BSL Bioservice Scientific Laboratories Munich GmbH, Cleancells, CordLife Group Ltd and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY
Load Cell Market Key Player Analysis By Single Point Load Cell, Compression Load …
The Load Cell Report consists of all the basic information regarding the Load Cell market. The all-inclusive report will aid users to understand the market current trends, industry growth drivers, share, analysis, size, production, forecast trends, supply, sales, demands, and many other aspects. The analysis was accomplished using an objective amalgamation of primary and secondary data including contributions from major participants in the market. The global Load Cell report is
Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell …
Researchmoz added Most up-to-date research on "Global Stem Cell Storage Market By Product Type - Umbilical Cord Blood Stem Cell, Embryonic Stem Cell & Adult Stem Cell" to its huge collection of research reports. In this report, the global Stem Cell Storage market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between
Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem …
Researchmoz added Most up-to-date research on "Stem Cell Media Sales In Global Market, 2017: By Product Type - Pluripotent Stem Cell Culture, Neural Stem Cell Culture & Mesenchymal Stem Cell Culture" to its huge collection of research reports. In this report, the global Stem Cell Media market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a